Prognostic value of tissue inhibitor of metalloproteinase-matrix metalloproteinase biomarkers at 30 days in patients with acute myocardial infarction without reperfusion therapy.

Pang, Hui-Fang; Gao, Yan; Liu, Jia-Min; Lu, Jia-Peng; Wang, Yan-Ping; Wang, Si-Ming; Hou, Li-Bo; Tian, Ao-Xi; Gao, Yan

Pang, Hui-Fang; Gao, Yan; Liu, Jia-Min; Lu, Jia-Peng; Wang, Yan-Ping; Wang, Si-Ming; Hou, Li-Bo; Tian, Ao-Xi; Gao, Yan.

Afiliação

Pang HF; National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Center for Cardiovascular Diseases, Beijing 100037, China.

Chin Med J (Engl) ; 134(4): 481-483, 2020 Oct 20.

Article em En | MEDLINE | ID: mdl-33093280

Assuntos

Metaloproteinases da Matriz; Infarto do Miocárdio; Inibidores Teciduais de Metaloproteinases; Biomarcadores; Humanos; Infarto do Miocárdio/diagnóstico; Prognóstico; Reperfusão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores Teciduais de Metaloproteinases / Metaloproteinases da Matriz / Infarto do Miocárdio Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google